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ABSTRACT 
The use of Traditional medicinal products continues to grow rapidly across all over the world 
while the safety of these products has been raised. As the last century saw a predominance of 
communicable disorders this century can be considered as a century of Non communicable 
Diseases. The main issue here is people consuming traditional medicine along with contemporary 
with a preoccupied thought that these medicines are free from adverse effects. But all traditional 
systems are not like that. Ayurveda which is a complete and ancient system with the present aim 
of accomplishment of physical, mental, social and spiritual well being at a global front. Even 
though substitution, adulteration, improper focus on quality is pulling down the popularity of 
Ayurveda, hence purity and safety of Ayurvedic medicines along with strict Standardization is 
need of an hour. 
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INTRODUCTION 
The standardization of drugs is the 
confirmation of its identity, quality and purity of the 
drug and later the reproducibility. Standardization 
also ensures the drug is safe throughout all its life 
including production, shelf-life and how long it can be 
used after opened. To standardize the creation and 
purity of Ayurvedic drugs is important to ensure the 
safety of a consumer and those who handle the drug. 
It also helps ensure that a consumer or patient is 
receiving the same product every time they use the 
drug. Standardizing drugs also ensures that they are 
receiving the highest quality of raw ingredients and 
herbs1. The challenge with standardization of 
Ayurvedic drugs and herbs is the lack of clear 
enforced guidelines on how herbs and oils need to be 
prepared, in what type of controlled environment 
and prepared by WHO. Another challenge with 
standardization is that if guidelines are in place, they 
differ depending on the country those drugs and 
herbs are used. Finally, the overall lack of research by 
the scientific community currently dedicated solely 
to Ayurvedic drugs, makes it difficult for drugs to be 
reproduced and standardized if doctors or 
consumers have no context to how they were 
created, prepared and kept.  
Ayurvedic drug standardization is controlled 
under the Drugs and Cosmetics Act of 1940. Under 
this act, it is written how drugs must be packaged, 
and the product must follow certain guidelines, to 
ensure safety and quality. The guidelines exist but 
many times they are not followed or not enforced, 
which endangers consumers and handlers of these 
drugs. It can be poisonous to some patients and 
educe toxic reactions in the body. Any and all risks 
should be advertised in the packaging of drugs and 
herbal products. In a survey study conducted by the 
Department of Clinical Pharmacology, TNMC and BYL 
Nair Ch. Hospital in Mumbai, headed by Dr. Supriya 
Bhalerao, the prevalence of mislabeling or ignoring 
aspects of the Drug and Cosmetic Act was revealed. 
Found on all the Ayurvedic drug container labels was 
basic manufacturing details, references from 
authoritative books were mentioned in about 90%. 
Only about 55% of classical formulations mentioned 
an ingredient list, and only about 20% of classical 
formulations labeled any form of warning or 
cautions2.When these guidelines are not followed by 
manufacturers, it endangers the consumer of these 
products. This will compromise any strides the 
government takes to change and increase the laws 
and guidelines surrounding the standardization of 
herbs and Ayurvedic drugs. The lack of warning and 
advised dosage for these drugs is very serious and 
can cause irrational use or abuse of these drugs by a 
consumer. The Ayurveda community cannot look 
forward to the standardization of their drugs and 
safety for their patients before clear guidelines are 
enforced or they are further outlined in the Drugs 
and Cosmetics Act of 1940. 
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Another challenge in the standardization of 
Ayurvedic drugs is how widespread and international 
Ayurvedic medicine is now, rather than just in India, 
holistic medicine has reached the western world. In a 
paper released by the PCTE Institute of Pharmacy, 
they claimed that, “There is no legal control model 
over medicinal plants. Different countries define 
medicinal plants or products derived from them in 
different ways and have adopted different 
approaches to licensing, dispensing, manufacturing 
and trading to ensure their safety, quality and 
efficacy”3. For example, in the United States, 
according to Mike Levy, Director of the Division of 
New Drugs and Labeling Compliance in the Office of 
Compliance, part of FDA's Center for Drug Evaluation 
and Research (CDER), Ayurvedic drugs, “are not 
generally reviewed or approved by the Food and 
Drug Administration (FDA)4. While in India 
Ayurvedic drugs need to have stronger, enforced 
guidelines, in the United States they need guidelines 
to be written and the FDA to be involved in these 
processes. Ayurvedic drugs and herbs are sold in the 
U.S either online illegally or they are advertised as 
dietary supplements, therefore do not need to follow 
and be held accountable for the same tests and 
standardization practices that regular FDA approved 
drugs must be. By no means are all Ayurvedic drugs 
dangerous or should be illegal in the United States, 
they are very useful and helpful to patients in the 
right hands of a trained professional. These drugs 
however, need to be standardized even when leaving 
India, it is the duty of the U.S FDA to be proactive in 
standardizing these medicines and be held 
responsible for the safety of international products 
being shipped and sold to United States residents.  
It is important to note that research and the 
need for standardization go hand in hand. To have a 
successful standardization guidelines and process, 
there needs to be research on the herbs used and 
their reactions with and outside of the body. To 
properly research these reactions and benefits of 
these drugs and herbs, there needs to be an ability of 
replication of the drugs, therefore standardization 
practices must exist. The problem arises that in this 
modern era any research that is being conducted 
involving Ayurveda and its drugs are not benefiting 
the ancient medicine. Much of the research into 
Ayurveda is for the direct benefit and extend modern 
bioscience. According to Gokarn, S. Gokarn, R. the 
authors and researched of Problems faced in 
Ayurvedic Drug Research, “There are only few data 
bases such Researches in Ayurveda published by 
which provide information about Researches done all 
over India”5. Research should be centered around 
helping develop Ayurvedic practices rather than the 
extension of modern bioscience and medicine. With 
this focus on research consumers and prescribers 
will be able to more accurately and safely understand 
the drugs they are consuming or prescribing to a 
patient. Making the medical community aware of the 
proper documentation and publication could make 
research and develop for drug standardization more 
successful.  
Standardization is very important to ensure 
the protection of consumers and the integrity of 
doctors and assistants. Many challenges arise out of 
this standardization of these drugs such as the lack of 
written and enforced guidelines from the 
government and medical boards for drugs. Also, the 
international guidelines need to be clear on the 
imports and exports into other countries such as the 
United States. Finally, the lack of research solely done 
on Ayurvedic drugs is a challenge to standardization 
practices and efforts as it makes it difficult to ensure 
replication of the drugs and analyze any 
consequences of taking those drugs. The Indian 
government must make strides for this 
standardization to ensure the safety for consumers 
both domestically and internationally. Making sure 
that consumers are receiving the same standardized 
drugs and herbs makes the benefits of these drugs 
greater and ensures that benefits are repeatable for 
many consumers, and holistic natural healing 
remains possible for future generations.  
DISCUSSION  
Ayurveda, traditional system of medicine of 
India is serving about 80% of Indian population. Most 
of the scholars are under impression that Ayurveda 
means it is Traditional Indian Herbal System. As like 
the other systems existing in the word like TCM 
(Traditional Chinese System of medicine) or Kempo 
(Japanese traditional system of medicine) Scholars 
must study the herbs and other sources as well as its 
various dosage modalities mentioned in Ayurvedic 
treatise. As above some scholars misinterpreted 
Ayurvedic drugs or its dosage modalities. De Smet7 
reviewed and comparing with system like TCM, He 
has listed 127 references, and reviewed on four 
Chinese herbs Ginkgo biloba, Hawthorn, Saw 
palmetto, and St. John's wort. While Many herbal 
compound are not properly described in the 
composition, they are sold on over the counter use 8. 
But there is no clear indication of medical fraternities 
role as William Osler rightly mentioned “Learn to see, 
learn to hear, learn to feel, learn to smell, and know 
that by practice alone can you become expert” 
Though, adverse effects associated with herbal 
products. Japanese Ministry of Health, Labor and 
Welfare says that Chinese dietary supplements can 
damage liver9. Ayurveda focus on healthy natural 
products There are hundreds of natural products are 
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mentioned in Ayurvedic treatise. The intent are not 
providing an exclusive review on DSHEA (Food 
material other than drugs) Neutaraceuiticals. There 
are hundreds of databases available to gather more n 
formation about them. It is advocated that better to 
use natural products with better precautions. But in 
Ayurvedic medicine if you standardized as per 
Ayurveda siddanta (Principle). It will better to collect 
the information about Ayurvedic drugs in MEDLINE 
(Medical analysis and retrial system) Cochrane, 
Indian Ayurvedic Pharmacopeia Published by 
Government of India. Bhasmas (Incinerated or 
calcinated preparation) are unique Ayurvedic 
metallic preparations with herbal juices mentioned in 
Ayurvedic classics10. The authors of Traditional 
medicine. to approach for drug discovery maximum 
extent about reverse pharmacology11 and as 
Ayurvedic classics mentions we are also think about 
Networking pharmacology. When C.P Thakur was the 
health minister of India, He was very keen to bring in 
CAM as a part of teaching and training programme in 
AIIMS, Delhi. Because of the severe objections of 
faculty of AIIMS he could’t introduced CAM at that 
stage. Carry on message-What Rodalph Virchow said, 
He said “Medicine is a social science and politics is 
nothing but medicine on a large scale.  
CONCLUSION 
Every system has its own loopholes from 
infrastructure to lack of well experienced staffs. 
While it is our duty to not accepting blindly anything 
also as well as not promoting quackery. at a present 
around 200 universities running various kind of 
Ayurveda courses. It is clear there is no NEW method 
is required if we standardize drug by Aptopadesh i.e., 
method told in the different Ayurveda treatise. It is 
our duty to understand where exactly evidences 
required and where understanding is required. It is 
necessary for us to prepare Ayurveda standardized 
or prepare as per medicine Ayurveda pharmacopeia. 
But as we are in the era of Globalization we have to 
concentrate on standardization using advance 
technology need to study the herb-drug interactions 
etc. and make it evidence based medicine. 
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